NEWSROOM

Press Releases
In the News
Logo & Resources Library

Recent News

News Update
Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal
October 27, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results...
Press Release
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
October 17, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced a partnership with Nkarta, Inc. (Nasdaq:...
Press Release
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network 
October 24, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announces a partnership with AbbVie Inc. for the...
News Update
Lupus Therapeutics PALS Program Expansion
October 1, 2023
Call for Individuals to Serve as a Trained Peer Educator Lupus Therapeutics, the clinical affiliate of Lupus Research Alliance, is...
Press Release
Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia to Increase Diversity in Lupus Clinical Research
June 29, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced the launch of three pilot research...
Press Release
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
June 2, 2023
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic...
News Update
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio, Inc. that...
Press Release
Lupus Research Alliance Appoints New Executive Vice President of Affiliate Lupus Therapeutics
January 17, 2023
The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie J. Bell, PhD as Executive Vice...
Press Release
Promising Data Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
November 8, 2022
ACR Convergence 2022 Included LRA-Authored Research on Measures to Demonstrate Treatment Efficacy for Patients with Lupus The Lupus Research Alliance...
News Update
NIH Awards $500,000 to Advance to Advance Diversity in Lupus Trials
August 31, 2022
We are excited to share good news – our Lupus Clinical Investigators Network, LuCIN, managed by LRA’s affiliate Lupus...
News Update
New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus
August 21, 2022
We are pleased to share positive results from the two-part Phase 2 LILAC study published in the New England Journal...
News Update
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
June 1, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new...